476 related articles for article (PubMed ID: 30678043)
1. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
[TBL] [Abstract][Full Text] [Related]
2. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
Bellini L; Campana M; Mahfouz R; Carlier A; Véret J; Magnan C; Hajduch E; Le Stunff H
Expert Opin Ther Targets; 2015; 19(8):1037-50. PubMed ID: 25814122
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
4. [Ceramides, crucial actors in the development of insulin resistance and type 2 diabetes].
Tan-Chen S; Bourron O; Hajduch É
Med Sci (Paris); 2020 May; 36(5):497-503. PubMed ID: 32452372
[TBL] [Abstract][Full Text] [Related]
5. Review: Lipid biology in the periparturient dairy cow: contemporary perspectives.
McFadden JW
Animal; 2020 Mar; 14(S1):s165-s175. PubMed ID: 32024571
[TBL] [Abstract][Full Text] [Related]
6. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
7. Short communication: Circulating fatty acylcarnitines are elevated in overweight periparturient dairy cows in association with sphingolipid biomarkers of insulin resistance.
Rico JE; Zang Y; Haughey NJ; Rius AG; McFadden JW
J Dairy Sci; 2018 Jan; 101(1):812-819. PubMed ID: 29103713
[TBL] [Abstract][Full Text] [Related]
8. Ceramides in insulin resistance and lipotoxicity.
Summers SA
Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
[TBL] [Abstract][Full Text] [Related]
9. Targeting ceramide metabolism in obesity.
Aburasayn H; Al Batran R; Ussher JR
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E423-35. PubMed ID: 27382035
[TBL] [Abstract][Full Text] [Related]
10. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
11. Ceramide analog C2-cer induces a loss in insulin sensitivity in muscle cells through the salvage/recycling pathway.
Bandet CL; Tan-Chen S; Ali-Berrada S; Campana M; Poirier M; Blachnio-Zabielska A; Pais-de-Barros JP; Rouch C; Ferré P; Foufelle F; Le Stunff H; Hajduch E
J Biol Chem; 2023 Jun; 299(6):104815. PubMed ID: 37178918
[TBL] [Abstract][Full Text] [Related]
12. The Role of Fatty Acids in Ceramide Pathways and Their Influence on Hypothalamic Regulation of Energy Balance: A Systematic Review.
Reginato A; Veras ACC; Baqueiro MDN; Panzarin C; Siqueira BP; Milanski M; Lisboa PC; Torsoni AS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069652
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.
Holland WL; Brozinick JT; Wang LP; Hawkins ED; Sargent KM; Liu Y; Narra K; Hoehn KL; Knotts TA; Siesky A; Nelson DH; Karathanasis SK; Fontenot GK; Birnbaum MJ; Summers SA
Cell Metab; 2007 Mar; 5(3):167-79. PubMed ID: 17339025
[TBL] [Abstract][Full Text] [Related]
14. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
15. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
Broskey NT; Obanda DN; Burton JH; Cefalu WT; Ravussin E
Metabolism; 2018 May; 82():118-123. PubMed ID: 29307520
[TBL] [Abstract][Full Text] [Related]
17. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
19. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
Brøns C; Grunnet LG
Eur J Endocrinol; 2017 Feb; 176(2):R67-R78. PubMed ID: 27913612
[TBL] [Abstract][Full Text] [Related]
20. A single prior bout of exercise protects against palmitate-induced insulin resistance despite an increase in total ceramide content.
Thrush AB; Harasim E; Chabowski A; Gulli R; Stefanyk L; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1200-8. PubMed ID: 21325642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
